.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
McKinsey
Julphar
Medtronic
Dow
Cipla
Fish and Richardson
Citi
Accenture
Chubb

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078649

« Back to Dashboard
NDA 078649 describes SULFACETAMIDE SODIUM, which is a drug marketed by Fougera Pharms, Akorn, Perrigo Co Tennessee, Pharmafair, Sandoz Inc, Bausch And Lomb, Taro, and Alcon Pharms Ltd, and is included in twelve NDAs. It is available from seventeen suppliers. Additional details are available on the SULFACETAMIDE SODIUM profile page.

The generic ingredient in SULFACETAMIDE SODIUM is prednisolone sodium phosphate; sulfacetamide sodium. There are eighty-five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate; sulfacetamide sodium profile page.

Summary for NDA: 078649

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 078649

Ingredient-typeSulfonamides

Suppliers and Packaging for NDA: 078649

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SULFACETAMIDE SODIUM
sulfacetamide sodium
LOTION;TOPICAL 078649 ANDA Perrigo New York Inc 45802-896 45802-896-26 1 BOTTLE, PLASTIC in 1 CARTON (45802-896-26) > 118 mL in 1 BOTTLE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength10%
Approval Date:Mar 23, 2009TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
QuintilesIMS
Accenture
Cantor Fitzgerald
Mallinckrodt
Teva
Deloitte
Novartis
Healthtrust
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot